CD34+ cell dose and CD33- subsets: Collection and engraftment kinetics in autologous peripheral blood stem cells transplantation

Haematologica

Volumn 83, Issue 6, 1998, Pages 489-495

  Mayol, Antonia Sampol ^a   Besalduch Vital, Joan ^a   Llodrá, Antoni Galmés ^a   Lleonart, Joan Bargay ^a   Flori, Nuria Matamoros ^a   Sureda, Miquel Morey ^a   García, Andrés Novo ^a   Riera, Martí Mascaró ^a   Bach, Elena González ^a   García, Pedro Martínez ^a  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

CD34; Growth factors; Hematopoiesis; Stem cells; Transplantation

Indexed keywords

ANTINEOPLASTIC AGENT; BUSULFAN; CARBOPLATIN; CARMUSTINE; CD33 ANTIGEN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; THIOTEPA;

ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW TRANSPLANTATION; CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CHILD; FEMALE; HEMATOPOIESIS; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; KINETICS; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA;

ADOLESCENT; ADULT; ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MIDDLE AGED; TRANSPLANTATION, AUTOLOGOUS;

EID: 0031820548     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. + hematopoietic progenitor cells in mobilized peripheral blood and bone marrow of cancer patients. Haematologica 1996; 81:216-23.
2. Andrews R, Singer J, Bernstein I. Monoclonal antibody 12.8 recognizes a 115 kd molecule present on both unipotent and multipotent colonies forming cells and their precursors. Blood 1986; 67:842-5.
3. Holyoake T, Alcorn M. CD34 positive haemopoietic cells: biology and clinical applications. Blood Rev 1994; 8:113-24.
4. +). Exp Hematol 1991; 9:680-2.
5. Bensinger W, Appelbaum F, Rowley S, et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 1995; 13:2547-55.
6. Douay L, Gorin N, Mary J, et al. Recovery of CFU-GM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment. Exp Hematol 1986; 14:358-65.
7. Brandwein J, Callum J, Sutcliffe S, et al. Analysis of factors affecting hematopoietic recovery after autologous bone marrow transplantation for lymphoma. Bone Marrow Transplant 1990; 6:291-4.
8. Weaver C, Hazelton B, Birch R, et al. An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995; 86:3961-9.
9. Galmés A, Besalduch J, Bargay J, et al. A simplified method for cryopreservation of hematopoietic stem cells with -80°C mechanical freezers with dimethyl sulfoxide as the sole cryoprotectant. Leuk Lymphoma 1995; 17:221-5.
10. Galmés A, Besalduch J, Bargay J, et al. Cryopreservation of hematopoietic blood cells with 5% dimethyl sulfoxide at -80°C without rate-controlled freezing. Transfusion 1996; 36:794-7.
11. Kaplan E, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958; 53: 457-81.
12. Cox DR. Regression models and life-tables. J R Stat Soc Series B 1972; 34:187-91.
13. DeLeo J. Receiver operating characteristic laboratory (ROCLAB): software for developing decision strategies that account for uncertainty. Proceedings of the Second International Symposium on Uncertainty Modeling and Analysis. IEEE Computer Society Press, 1993:318-25.
14. To L, Roberts M, Haylock D, et al. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 1992; 9:277-84.
15. D'Arena G, Musto P, Carotenuto M. When to perform peripheral blood progenitor cell collection in hematological patients? Haematologica 1997; 82:124-5.
16. Elliott C, Samson D, Armitage S, et al. When to harvest peripheral-blood stem cells after mobilization therapy: prediction of CD34-positive cell yield by preceding day CD34-positive concentration in peripheral blood. J Clin Oncol 1996; 14:970-3.
17. Bensinger W, Longin K, Appelbaum F, et al. Peripheral blood stem cells (PBSC's) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): An analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 1994; 87:825-31.
18. Haynes A, Hunter A, McQuaker G, et al. Engraftment characteristics of peripheral blood stem cells mobilised with cyclophosphamide and the delayed addition of G-CSF. Bone Marrow Transplant 1995; 16:359-63.
19. Zimmerman TM, Lee W, Mick R, Williams S. Quantitative CD34 analysis may be used to guide peripheral blood stem cell harvests. Bone Marrow Transplant 1995; 9:439-44.
20. + cells and rapid hematopoietic recovery after peripheral-blood stem cell transplantation. J Clin Oncol 1995; 13:1922-32.